Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2012-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1118067109PMID 22331909PMCID PMC3295269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatic coding mutations in human induced pluripotent stem cells

  2011cited by this paper
• HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene?

  2011cited by this paper
• Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?

  2010cited by this paper
• Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis.

  2010influential reference
• A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells.

  2010cited by this paper
• THE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE

  2010cited by this paper
• Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells

  2009influential reference
• Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.

  2009cited by this paper
• Trophic functions of nucleotides in the central nervous system.

  2009cited by this paper
• The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.

  2009cited by this paper
• Wnt signalling and its impact on development and cancer

  2008cited by this paper
• Purinergic signalling and disorders of the central nervous system

  2008cited by this paper
• The role of ATP signaling in the migration of intermediate neuronal progenitors to the neocortical subventricular zone

  2008influential reference
• Nerve growth factor‐stimulated neuronal differentiation induces changes in P2 receptor expression and nucleotide‐stimulated catecholamine release

  2007cited by this paper
• Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome

  2007cited by this paper
• New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders

  2007cited by this paper
• Gi‐coupled P2Y‐ADP receptor mediates GSK‐3 phosphorylation and β‐catenin nuclear translocation in granule neurons

  2007influential reference
• Nucleotide signaling in nervous system development

  2006influential reference
• Inhibition of Apoptosis by P2Y2 Receptor Activation: Novel Pathways for Neuronal Survival

  2006cited by this paper
• Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation

  2006cited by this paper
• P2 purinergic receptors signal to glycogen synthase kinase‐3β in astrocytes

  2006cited by this paper
• Involvement of P2 receptors in the growth and survival of neurons in the CNS.

  2006cited by this paper
• ATP Stimulates Mouse Embryonic Stem Cell Proliferation via Protein Kinase C, Phosphatidylinositol 3‐Kinase/Akt, and Mitogen‐Activated Protein Kinase Signaling Pathways

  2006cited by this paper
• INHERITED HYPERURICEMIC DISORDERS

  2005cited by this paper
• Inherited hyperuricemic disorders.

  2005cited by this paper
• The many faces of CREB.

  2005cited by this paper
• Supersensitivity of P2X7 receptors in cerebrocortical cell cultures after in vitro ischemia

  2005cited by this paper
• Altered membrane NTPase activity in Lesch–Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT‐deficient cell lines

  2005cited by this paper
• Behavioral aspects of Lesch-Nyhan disease and its variants.

  2005cited by this paper
• P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation.

  2005cited by this paper
• Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

  2004cited by this paper
• Targeting the CREB pathway for memory enhancers

  2003cited by this paper
• Abundant and dynamic expression of G protein‐coupled P2Y receptors in mammalian development

  2003cited by this paper
• beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system.

  2003cited by this paper
• Lineage-specific requirements of β-catenin in neural crest development

  2002cited by this paper
• Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients.

  2002cited by this paper
• Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

  2001cited by this paper
• Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.

  1999cited by this paper
• Selective expression of purinoceptor cP2Y1 suggests a role for nucleotide signalling in development of the chick embryo

  1999cited by this paper
• Implication of ATP receptors in brain functions.

  1996cited by this paper
• Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.

  1996cited by this paper
• Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.

  1981influential reference
• Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis

  1967cited by this paper
• A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION.

  1964cited by this paper

• Microcephaly-associated protein WDR62 supports purine metabolism by interacting with co-chaperone BAG2.

  2026cites this paper
• The Role of Purine Metabolism and Uric Acid in Postnatal Neurologic Development

  2025cites this paper
• One-Carbon Metabolism and Midbrain Dopaminergic Cells in Lesch-Nyhan Disease.

  2025cites this paper
• Changes in brain connectivity and neurovascular dynamics during dexmedetomidine-induced loss of consciousness

  2025cites this paper
• 1H and 13C NMR and FTIR Spectroscopic Analysis of Formic Acid Dissociation Dynamics in Water.

  2024cites this paper
• Sequential Deactivation Across the Hippocampus‐Thalamus‐mPFC Pathway During Loss of Consciousness

  2024cites this paper
• Unleashing the Power of Induced Pluripotent stem Cells in in vitro Modelling of Lesch-Nyhan Disease

  2024cites this paper
• Dissecting genetic architecture of rare dystonia: genetic, molecular and clinical insights

  2024cites this paper
• Dissecting SOX2 expression and function reveals an association with multiple signaling pathways during embryonic development and in cancer progression.

  2024cites this paper
• Inborn Errors of Purine Salvage and Catabolism

  2023cites this paper
• Purinergic Signaling and its Role in the Stem Cell Differentiation.

  2023cites this paper
• PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness

  2021cites this paper
• Induced pluripotent stem cells from subjects with Lesch-Nyhan disease

  2021cites this paper
• Inborn errors of metabolism: Lessons from iPSC models

  2021cites this paper
• Caveolin-1 Expression in the Dorsal Striatum Drives Methamphetamine Addiction-Like Behavior

  2021cites this paper
• Lesch-Nyhan disease: I. Construction of expression vectors for hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme and amyloid precursor protein (APP)

  2020influential citation
• Animal Model Contributions to Congenital Metabolic Disease.

  2020cites this paper
• In vivo reduction of striatal D1R by RNA interference alters expression of D1R signaling-related proteins and enhances methamphetamine addiction in male rats

  2020cites this paper
• Organs to Cells and Cells to Organoids: The Evolution of in vitro Central Nervous System Modelling

  2019cites this paper
• Animal and cell models for Lesch-Nyhan syndrome

  2019cites this paper
• Formate metabolism in health and disease

  2019cites this paper
• Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors

  2018cites this paper
• Lesch-Nyhan disease: A rare disorder with many unresolved aspects

  2018cites this paper
• Purinergic Receptor Expression and Potential Association with Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Development

  2017cites this paper
• Temporal expression divergence of network modules

  2017cites this paper
• The hypothesis that Helicobacter pylori predisposes to Alzheimer’s disease is biologically plausible

  2017cites this paper
• Dynamic reconfiguration of cortical functional connectivity across brain states

  2017cites this paper
• Antipurinergic therapy for autism-An in-depth review.

  2017cites this paper
• Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders

  2016cites this paper
• Purinergic receptors in embryonic and adult neurogenesis.

  2016cites this paper
• Alzheimer's disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch-Nyhan disease).

  2015cites this paper
• Intrinsic coupling modes reveal the functional architecture of cortico-tectal networks

  2015cites this paper
• A Mechanistic Neural Field Theory of How Anesthesia Suppresses Consciousness: Synaptic Drive Dynamics, Bifurcations, Attractors, and Partial State Equipartitioning

  2015cites this paper
• How the cortico-thalamic feedback affects the EEG power spectrum over frontal and occipital regions during propofol-induced sedation

  2015cites this paper
• Nucleotide Salvage Deficiencies, DNA Damage and Neurodegeneration

  2015cites this paper
• Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

  2015cites this paper
• Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf

  2015cites this paper
• Modeling Neurodevelopmental Disorders Using Human Pluripotent Stem Cells

  2014cites this paper
• Dietary Inulin Supplementation Modifies Significantly the Liver Transcriptomic Profile of Broiler Chickens

  2014cites this paper
• The role of purinergic receptors in stem cell differentiation

  2014cites this paper
• Transcriptomic Approach to Lesch-Nyhan Disease

  2014cites this paper
• Striatal Neurodevelopment Is Dysregulated in Purine Metabolism Deficiency and Impacts DARPP-32, BDNF/TrkB Expression and Signaling: New Insights on the Molecular and Cellular Basis of Lesch-Nyhan Syndrome

  2014cites this paper
• Light‐controlled astrocytes promote human mesenchymal stem cells toward neuronal differentiation and improve the neurological deficit in stroke rats

  2014cites this paper
• Deficiency of the purine metabolic gene HPRT dysregulates microRNA-17 family cluster and guanine-based cellular functions: a role for EPAC in Lesch-Nyhan syndrome.

  2013cites this paper
• HIV-1 TAT-mediated protein transduction of human HPRT into deficient cells.

  2013cites this paper
• N-Glycoproteome of E14.Tg2a Mouse Embryonic Stem Cells

  2013cites this paper
• The Housekeeping Gene Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Regulates Multiple Developmental and Metabolic Pathways of Murine Embryonic Stem Cell Neuronal Differentiation

  2013cites this paper
• Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling

  2013cites this paper
• Local cortical dynamics of burst suppression in the anaesthetized brain

  2013cites this paper
• HPRT-Deficiency Dysregulates cAMP-PKA Signaling and Phosphodiesterase 10A Expression: Mechanistic Insight and Potential Target for Lesch-Nyhan Disease?

  2013cites this paper
• Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch–Nyhan disease: BODIPY–forskolin as pharmacological tool

  2012cites this paper
• Human disease modeling with induced pluripotent stem cells.

  2012cites this paper